The 22nd PIA Regulatory Conference confirmed that AI will continue to profoundly transform the pharmaceutical industry. #NewsismyBusiness
The biopharmaceutical industry contributes 18% of the island's Gross Domestic Product.
The Pharmaceutical Industry Association of Puerto Rico (PIA-PR) hosted the 16th FDA Regulatory Conference with nine speakers that presented top priorities for pharmaceutical manufacturing across the globe, new technologies as voice recognition and how to effectively transition from paper to mobile, among other key topics.
Puerto Rico’s pharmaceutical manufacturing sector took a major hit from Hurricanes Irma and María in September, but are in recovery mode and back in production to ensure continuity in the availability of medications in Puerto Rico and globally, Jaime Palacios, president of the Pharmaceutical Industry Association said Wednesday.
Puerto Rico's private-sector community continued Thursday to display an outpouring of support for the victims of Hurricane Irma, launching efforts to help rebuild.
Puerto Rican executives continue to climb the corporate ladder both in Puerto Rico and abroad, in a spectrum of economic sectors.
The Pharmaceutical Industry Association of Puerto Rico and the federal Food and Drug Administration will host the FDA/PIA 12th Regulatory Meeting Thursday at the Ritz-Carlton San Juan, from 7:30 a.m. to 5 p.m, the trade group announced.
The Pharmaceutical Industry Association of Puerto Rico (PIA) expressed “extreme concern” with the critical situation Puerto Rico is facing will be going through in the near future, magnified by the recent credit downgrade by Standard & Poor’s and Moody’s, which the trade group said will “require us to make essential changes in the way the […]
It was five years ago that manufacturing giant GlaxoSmithKline North America Pharmaceuticals took a step back to assess the way it was doing business.
The Puerto Rico Pharmaceutical Industry Association will be hosting its 24th annual convention this week, when local and stateside speakers will discuss strategies that companies can apply to transform for a better future — this year’s theme.
The Puerto Rico Pharmaceutical Industry Association is lobbying for giving island patients broader access to innovative drugs and treatments, and against the final decision being made by anyone other than the prescribing physician.
The Pharmaceutical Industry Association of Puerto Rico will be holding its “Health System Reform and the Quality of Healthcare” summit Sept. 14 to provide a forum for healthcare industry professionals to share ideas about trends and practices that influence the health outcomes for the local community.
NIMB ON SOCIAL MEDIA